You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 5, 2024

ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for acetaminophen; propoxyphene napsylate and what is the scope of patent protection?

Acetaminophen; propoxyphene napsylate is the generic ingredient in five branded drugs marketed by Xanodyne Pharm, Teva, Able, Actavis Elizabeth, Cornerstone, Halsey, Ivax Sub Teva Pharms, Mallinckrodt, Mirror Pharms, Mutual Pharm, Mylan, Mylan Pharms Inc, Sandoz, Superpharm, Vintage Pharms, Watson Labs, Watson Labs Florida, and Wockhardt Ltd, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

Summary for ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
US Patents:0
Tradenames:5
Applicants:18
NDAs:29
DailyMed Link:ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE at DailyMed

US Patents and Regulatory Information for ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mutual Pharm PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN acetaminophen; propoxyphene napsylate TABLET;ORAL 070775-001 Mar 21, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mutual Pharm PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN acetaminophen; propoxyphene napsylate TABLET;ORAL 070771-001 Mar 21, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN acetaminophen; propoxyphene napsylate TABLET;ORAL 072195-001 Feb 16, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Pharms Inc PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN acetaminophen; propoxyphene napsylate TABLET;ORAL 070145-001 Jun 12, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.